Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,308
archived clinical trials in
Hepatitis

Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Open-Label, Multiple-Dose, Dose Escalation Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Coadministration of BMS-650032, BMS-790052, and BMS-791325 When Administered for 24 or 12 Weeks in Treatment-Naïve Subjects Infected With Hepatitis C Virus Genotype 1
Status: Enrolling
Updated:  4/26/2017
Southwest CARE Center
mi
from
Santa Fe, NM
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Open-Label, Multiple-Dose, Dose Escalation Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Coadministration of BMS-650032, BMS-790052, and BMS-791325 When Administered for 24 or 12 Weeks in Treatment-Naïve Subjects Infected With Hepatitis C Virus Genotype 1
Status: Enrolling
Updated: 4/26/2017
Southwest CARE Center
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Open-Label, Multiple-Dose, Dose Escalation Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Coadministration of BMS-650032, BMS-790052, and BMS-791325 When Administered for 24 or 12 Weeks in Treatment-Naïve Subjects Infected With Hepatitis C Virus Genotype 1
Status: Enrolling
Updated:  4/26/2017
James J Peters Vamc
mi
from
The Bronx, NY
Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications
Open-Label, Multiple-Dose, Dose Escalation Study to Evaluate the Pharmacodynamics, Pharmacokinetics, and Safety of Coadministration of BMS-650032, BMS-790052, and BMS-791325 When Administered for 24 or 12 Weeks in Treatment-Naïve Subjects Infected With Hepatitis C Virus Genotype 1
Status: Enrolling
Updated: 4/26/2017
James J Peters Vamc
mi
from
The Bronx, NY
Click here to add this to my saved trials
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
Status: Enrolling
Updated:  5/1/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
Status: Enrolling
Updated: 5/1/2017
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
Status: Enrolling
Updated:  6/27/2017
GSK Investigational Site
mi
from
Chula Vista, CA
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
Status: Enrolling
Updated: 6/27/2017
GSK Investigational Site
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
Status: Enrolling
Updated:  6/27/2017
GSK Investigational Site
mi
from
Lenexa, KA
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
Status: Enrolling
Updated: 6/27/2017
GSK Investigational Site
mi
from
Lenexa, KA
Click here to add this to my saved trials
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
Status: Enrolling
Updated:  6/27/2017
GSK Investigational Site
mi
from
Willingboro, NJ
A First Time in Human Study to Assess GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Patients.
A Randomized, Double Blind, Dose Escalation, Fusion, First Time in Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Single and Repeat Doses of GSK2336805 in Healthy Volunteers and Single Doses in Chronically Infected Hepatitis C Subjects
Status: Enrolling
Updated: 6/27/2017
GSK Investigational Site
mi
from
Willingboro, NJ
Click here to add this to my saved trials
The Health Access and Recovery Peer Program
A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
Status: Enrolling
Updated:  7/12/2017
Central Fulton Community Mental Health Center at Grady Hospital
mi
from
Atlanta, GA
The Health Access and Recovery Peer Program
A Peer-Led, Medical Disease Self-Management Program for Mental Health Consumers
Status: Enrolling
Updated: 7/12/2017
Central Fulton Community Mental Health Center at Grady Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Parkway Medical Center /ID# 130299
mi
from
Birmingham, AL
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Parkway Medical Center /ID# 130299
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Medical Associates Research Group /ID# 130290
mi
from
San Diego, CA
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Medical Associates Research Group /ID# 130290
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
University of Colorado Cancer Center /ID# 130292
mi
from
Aurora, CO
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
University of Colorado Cancer Center /ID# 130292
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Gastroenterology Group of Naples /ID# 130295
mi
from
Naples, FL
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Gastroenterology Group of Naples /ID# 130295
mi
from
Naples, FL
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Carolinas Center For Liver Disease /ID# 130297
mi
from
Statesville, NC
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Carolinas Center For Liver Disease /ID# 130297
mi
from
Statesville, NC
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Gastro One /ID# 130300
mi
from
Germantown, TN
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Gastro One /ID# 130300
mi
from
Germantown, TN
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Texas Liver Institute / American Research Corporation /ID# 130296
mi
from
San Antonio, TX
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Texas Liver Institute / American Research Corporation /ID# 130296
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Clinical Research Centers of America, LLC /ID# 130291
mi
from
Murray, UT
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Clinical Research Centers of America, LLC /ID# 130291
mi
from
Murray, UT
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
Virginia Mason Medical Center /ID# 130294
mi
from
Seattle, WA
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
Virginia Mason Medical Center /ID# 130294
mi
from
Seattle, WA
Click here to add this to my saved trials
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated:  7/12/2017
University Gastroenterology /ID# 130298
mi
from
Providence, RI
A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Sofosbuvir and RBV in DAA Treatment-experienced Adults With Chronic Hepatitis C Virus Infection
An Open-Label Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Ombitasvir/ABT-450/Ritonavir (Ombitasvir/ABT-450/r) and Dasabuvir Co-administered With or Without Sofosbuvir (SOF) and Ribavirin (RBV) in Direct-Acting Antiviral Agent (DAA) Treatment-Experienced Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling
Updated: 7/12/2017
University Gastroenterology /ID# 130298
mi
from
Providence, RI
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Mayo Clinic Arizona /ID# 90539
mi
from
Phoenix, AZ
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Mayo Clinic Arizona /ID# 90539
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
University of California, San Francisco /ID# 90538
mi
from
San Francisco, CA
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
University of California, San Francisco /ID# 90538
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
University of Colorado Cancer Center /ID# 90535
mi
from
Aurora, CO
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
University of Colorado Cancer Center /ID# 90535
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Northwestern University /ID# 90562
mi
from
Chicago, IL
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Northwestern University /ID# 90562
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
The University of Chicago Medical Center /ID# 90563
mi
from
Chicago, IL
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
The University of Chicago Medical Center /ID# 90563
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Indiana University /ID# 90536
mi
from
Indianapolis, IN
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Indiana University /ID# 90536
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Lahey Clinic Hospital and Medical Center /ID# 100055
mi
from
Burlington, MA
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Lahey Clinic Hospital and Medical Center /ID# 100055
mi
from
Burlington, MA
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Henry Ford Health System /ID# 125419
mi
from
Detroit, MI
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Henry Ford Health System /ID# 125419
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Columbia University Medical Center /ID# 90533
mi
from
New York, NY
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Columbia University Medical Center /ID# 90533
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
The Liver Institute at Methodist Dallas Medical Ctr /ID# 90537
mi
from
Dallas, TX
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
The Liver Institute at Methodist Dallas Medical Ctr /ID# 90537
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Baylor University Medical Center /ID# 96250
mi
from
Dallas, TX
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Baylor University Medical Center /ID# 96250
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated:  7/28/2017
Royal Prince Alfred Hospital /ID# 123975
mi
from
Camperdown,
A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients
Open-Label, Phase 2 Study to Evaluate the Safety and Efficacy of the Combination of ABT-450/Ritonavir/ABT-267 With ABT-333 and With or Without RBV in HCV Genotype 1 and ABT-450/r/ABT-267 With RBV in HCV GT4-Infected Adult Liver or Renal Transplant Recipients With Hepatitis C Virus (HCV) Infection (CORAL-I)
Status: Enrolling
Updated: 7/28/2017
Royal Prince Alfred Hospital /ID# 123975
mi
from
Camperdown,
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
University of California at San Francisco
mi
from
San Francisco, CA
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
University of Miami School of Medicine
mi
from
Miami, FL
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
Rush University
mi
from
Chicago, IL
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
Rush University
mi
from
Chicago, IL
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
University of Maryland School of Medicine
mi
from
Baltimore, MD
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
University of Maryland School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
New York-Presbyterian Medical Center
mi
from
New York, NY
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
New York-Presbyterian Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated:  8/2/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Hepatitis C Antiviral Resistance in African-Americans
Study of Viral Resistance to Antiviral Therapy of Chronic Hepatitis C (Virahep-C)
Status: Enrolling
Updated: 8/2/2017
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment
A Prospective and Open-Label Study of the Effect on Proximal Tubular Function in Asian-American Patients Receiving Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) for HBV Treatment
Status: Enrolling
Updated:  9/5/2017
New Discovery LLC
mi
from
New York, NY
Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment
A Prospective and Open-Label Study of the Effect on Proximal Tubular Function in Asian-American Patients Receiving Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) for HBV Treatment
Status: Enrolling
Updated: 9/5/2017
New Discovery LLC
mi
from
New York, NY
Click here to add this to my saved trials
Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment
A Prospective and Open-Label Study of the Effect on Proximal Tubular Function in Asian-American Patients Receiving Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) for HBV Treatment
Status: Enrolling
Updated:  9/5/2017
Asian Pacific Liver Center at St. Vincent Medical Center
mi
from
Los Angeles, CA
Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment
A Prospective and Open-Label Study of the Effect on Proximal Tubular Function in Asian-American Patients Receiving Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) for HBV Treatment
Status: Enrolling
Updated: 9/5/2017
Asian Pacific Liver Center at St. Vincent Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs
Status: Enrolling
Updated:  9/22/2017
Substance Use Research Unit
mi
from
San Francisco, CA
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs
Status: Enrolling
Updated: 9/22/2017
Substance Use Research Unit
mi
from
San Francisco, CA
Click here to add this to my saved trials
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated:  9/28/2017
BIDMC
mi
from
Boston, MA
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated: 9/28/2017
BIDMC
mi
from
Boston, MA
Click here to add this to my saved trials
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated:  9/28/2017
Duke Univ Med Ctr
mi
from
Durham, NC
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated: 9/28/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated:  9/28/2017
Bruce Bacon M.D.
mi
from
Saint Louis, MO
FibroScan in Patients With Hepatitis B and C Presenting for Liver Biopsy
Comparison of FibroScan With Histological Evaluations of Liver Fibrosis in Patients With Hepatitis B and C Presenting for Liver Biopsy
Status: Enrolling
Updated: 9/28/2017
Bruce Bacon M.D.
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated:  9/29/2017
Bon Secours St. Mary's Hospital of Richmond
mi
from
Newport News, VA
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated: 9/29/2017
Bon Secours St. Mary's Hospital of Richmond
mi
from
Newport News, VA
Click here to add this to my saved trials
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated:  9/29/2017
Digestive Disease Associates, PA
mi
from
Baltimore, MD
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated: 9/29/2017
Digestive Disease Associates, PA
mi
from
Baltimore, MD
Click here to add this to my saved trials
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated:  9/29/2017
Henry Ford Hospital
mi
from
Detroit, MI
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated: 9/29/2017
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated:  9/29/2017
Kaiser Permanente
mi
from
San Diego, CA
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated: 9/29/2017
Kaiser Permanente
mi
from
San Diego, CA
Click here to add this to my saved trials
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated:  9/29/2017
Kaiser Permanente
mi
from
San Francisco, CA
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated: 9/29/2017
Kaiser Permanente
mi
from
San Francisco, CA
Click here to add this to my saved trials
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated:  9/29/2017
Kaiser Permanente
mi
from
Sacramento, CA
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated: 9/29/2017
Kaiser Permanente
mi
from
Sacramento, CA
Click here to add this to my saved trials
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated:  9/29/2017
Medical Procare, PLL
mi
from
Flushing, NY
Long Term Follow-up Registry of Individuals Treated in A Gilead-Sponsored Trial in Individuals With Chronic Hepatitis B Infection
A Long Term Follow-up Registry of Subjects Treated in A Gilead-Sponsored Trial in Subjects With Chronic Hepatitis B Infection
Status: Enrolling
Updated: 9/29/2017
Medical Procare, PLL
mi
from
Flushing, NY
Click here to add this to my saved trials